Association between the Rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes. PLoS ONE, vol
It used the period following the Lipitor cliff to aggressively cut costs, return capital to shareholders, and pursue pipeline acquisitions that would eventually produce new blockbusters like Xeljanz, Eliquis (co-commercialized with BMS), and, ultimately, the COVID-19 vaccine and antiviral
Latvia Scientists have found that the administration of the GHRP-2 peptide could have the following effects: Stimulation of Growth Hormone Enhancing IGF-1 for Repair and Recovery GHRP-2 enhances IGF-1 production by stimulating the release of growth hormone (GH) from the pituitary gland
Investor Takeaway For investors seeking exposure to the GLP-1 boom in India, the key is to identify companies with proven capabilities in: Peptide synthesis Sterile injectable manufacturing Global regulatory compliance CDMO services with US/EU clients Recommended Monitoring: R&D updates and capacity expansions Any tie-ups with global GLP-1 players Clinical trial progress for biosimilar versions Regulatory approvals (USFDA, EMA) Export data to key markets (USA, Canada, China) Conclusion The weight loss drug boom is changing global healthcare and creating a huge business opportunity for Indian pharma companies
Think of your intestines as a finely tuned orchestra of contractions that propel food along
Unfortunately, I ended up with mixed results of variable quality
